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Abstract: Mesenchymal stem cells derived from bone marrow or several fetal tissues can be expanded and differentiated into
other cell lines. The fetal liver is the source of early hematopoietic cells and also, as a fetal tissue, may be considered as a
source of pluripotent stem cells. The differentiation potential of fetal rat liver cells have been examined. Freshly isolated liver
cells from 14-d fetuses were cultured in Dulbecco medium supplemented with 10% FCS. The plastic-adherent cells were then
passaged up to 10 times. Freshly isolated cells and cells from every passage were cultured in hematopoiesis-promoting
environment that consists of methylcelulose supplemented with FCS, rat IL-3, human IL-6 and Epo. Parallely these cells were
incubated in co-culture with rat muscle satellite cells (Dulbecco medium with 10% FCS and 10% HS) to examine their myogenic
potential. Culture in methylcelulose resulted in a high number of GM and Mix colonies in case of freshly isolated liver cells and the
number of colonies decreased according to the number of passages. In case of cells from 4th passage, there ware no hematopoietic
colonies in culture. In contrast - freshly isolated cells were not able to fuse with rat satellite cells and form the myotubes. This ability
appeared in plastic-adherent cells just from the second passage and increases to 5th passage. The cells from every next passage up
to 10th when co-cultured with satellite cells participated in myotube formation at the same high level. This result may suggest that
in the 14-d rat liver there exist at least two subpopulations of cells: the non-adherent hematopoietic cell population, and the population
of plastic-adherent cells capable of differentiating into myotubes. Since the attempts to redifferentiate hematopoietic subpopulation
into myopoiesis, or myopoietic subpopulation into hematopoiesis failed, it may be concluded that at least under our experimental
conditions the fetal liver cells do not reveal the "plasticity" features. 
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Sources of stem cells
Investigations of stem cell origin seem to be one of the
most rapidly advancing fields of the present biological
sciences [13 , 15, 30, 36]. Generally, the paradigm of
stem cells is that rare cells, which exist in several tissues,
are capable of both self-renewal and multilineage dif-
ferentiation [18, 20]. The open question is the selection
of the best source of these cells. It is clear that the
development potential of pluripotent embryonic stem
cells is much higher in comparison to fetal stem cells or
those isolated from adult tissues [39]. However, the
ethical dilemmas surrounding the use of embryonic cells
in cell therapy have encouraged the search for other
sources of these cells. The use of adult tissue-derived
stem cells for research or clinical purposes creates prob-
lems as well. Firstly, the paucity of molecular markers
can hinder the identification and quantification of stem
cells, moreover, the markers can vary depending on
culture condition and cell preparation; secondly, the
stem cells isolated from adult tissue can be heteroge-
neous and may not demonstrate the expected differen-
tiation at the single-cell level [24, 26, 28]. Moreover, the
idea of adult stem cell plasticity (i.e. concept of adult
tissue-derived stem cells transdifferentiation) is not
widely accepted and can be explained by spontaneus cell
fusion [35, 43] or by coexistence of many kinds of
tissue-specific stem cells in the adult tissues such as bone
marrow or muscle [31]. The other kind of cells which
seems to be promising as capable of maturation and
differentiation at the cell level are the fetal stem cell. As
compared to adult tissue-derived counterparts, the fetal
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stem cells have a bigger potential of proliferation and
differentiation, higher activity of telomerase and longer
telomeres what indicates the primitive origin of these
cells. Additionally, the pre-immune status of fetal stem
cells may play an important role in case of clinical trials
of allogenic mismatched cell therapy [12, 30]. The fetal
stem cells, including hematopoietic and mesenchymal
stem cells can be isolated from placenta, cord blood,
umbilical cord or fetal blood, bone marrow or liver [4,
10, 19, 25, 40, 42]. 
Hematopoietic stem cells in fetal liver 
Fetal liver is an organ which in mammalian hemato-
poiesis plays a particularly important role. During the
fetal development, the hematopoietic stem cells migrate
from the yolk sac to the liver which becomes the princi-
pal hematopoietic organ. In humans it persists from the
6th week trough mid-gestation and at that time the
hematopoietic CD34+ stem and progenitor cells may be
isolated from the liver in large quantities [37]. 
The CD34 antigen identifies a heterogeneous popu-
lation of cells. The earliest hematopoietic stem cells
should be enriched with cells with CD34+ CD38- li-
neage phenotype. During the differentiation process,
these cells acquire CD38 and then lose CD34 antigens.
There are many reports analyzing the hematopoietic
antigen properties on the surface of fetal liver cells.
Anderson et al. [2] and Gilles et al. [11] have quantified
the proportion of CD34 hematopoietic stem and pro-
genitor cells within fetal liver from 6th to 17th week of
gestation. They found that the quantity of CD34+ cells
in liver increased over four-fold reaching, according to
the authors, 2.6% [2] and 15% [11] in the 17th week.
This difference between the two independent investiga-
tions seems to result from different methods of prepara-
tion and counting the cells. Another report quantified the
proportion of CD34+ leukocytes in mid-gestation liver
as 17.5%7.8% [27]. The authors compared the subpopu-
lation of CD34+ cells in fetal blood and in fetal liver
between 10th and 17th week of gestation. In contrast to
fetal liver, the fetal blood showed a significant decrease
in CD34+ cells at that time. Both, total CD34+ hemato-
poietic cells and more primitive CD34+/ CD38- cells
constituted a significant proportion of leukocyte count
in the fetal liver. The proportion of the more primitive
hematopoietic cells was two times higher in fetal liver
than in fetal blood. These data and the fact that in the
fetal liver only few T lymphocytes were detected indi-
cate that this organ is a good source of hematopoietic
cells for research and clinical purposes [9, 27].
Non-hematopoietic stem cells in fetal liver
Apart from the hematopoietic stem and progenitor cells,
many other kinds of stem cells could be detected in the
fetal liver: cells which co-express CD34 and CK7/8
(cytokeratins 7 and 8) markers and which were proposed
to represent a common stem cell of the hepatic and
hematopoietic lineages [21, 32]; cells which have a
bipotential differentiation capacity towards liver and
biliary cells [33, 34]; fibroblast-like cells that have an
epithelial to mesenchymal transition phenotype [44] or
typical mesenchymal cells (MSC) with phenotype char-
acteristic for mesenchymal cells derived from cord
blood, umbilical cord Wharton’s jelly or placenta [5, 18,
39]. The fetal liver-derived mesenchymal cells have
similar appearence to adult mesenchymal cells and
Fig. 1. Fetal liver cells in culture, immediately after the 10th passage (left) and 10 days later - directly before the 11th passage (right).
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growth pattern as a fibroblast-like adherent cells. They
usually express a number of adhesion molecules such as
CD44 and CD29, and are positive for intracellular mar-
kers fibronectin, laminin, vimentin and also for specific
mesenchymal markers SH2, SH3 and SH4 but negative
for hematopoietic markers CD45 and CD34. Compared
to their adult counterparts, the mesenchymal stem cells
derived from fetal tissues, including fetal liver, have a
bigger expandable potential with a population doublings
every 30 hours as compared to 48-72 hours in case of
adult tissue-derived MSC, and do not show any import-
ant changes in their phenotype during at least 20 pas-
sages [4]. The proliferative capacity of fetal MSC is also
much higher as compared to adult MSC [5]. These cells,
under a special culture condition can differentiate in
vitro into at least three tissues: fat, bone and cartilage [1,
4, 7] and, as described by Chan et al. [6], into skeletal
muscle cells. Moreover, small differences in the dif-
ferentiation capacity of cells depend on the sources of
fetal MSC, for instance, the bone marrow- and liver-
Fig. 2. Satellite cell culture from soleus muscle. Intensive proliferation on the 4th day of culture (left) and confluent growth with myotubes
formed (right).
Fig. 3. Myotubes formed by cell fusion. PKH fluorescence is a marker of fetal liver cells; 7th day of culture - beginning of cell fusion process
(left) and 9th day - completely formed myotubes (right).
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derived MSC have a greater ability to adipogenic dif-
ferentiation but lower in case of osteogenic differentia-
tion [1, 7]. Anyway, the mesenchymal stem cells derived
from fetal liver and other fetal tissues seem to be very
promising tools in cell therapy and gene engineering and
the fetal liver appears as a good source of these cells. 
Stem cells and muscle
As mentioned above, the mesenchymal stem cell can
differentiate into several cell lines and this phenomenon
is the feature of MSC irrespective of their sources.
Makino et al. [22] demonstrated the ability of bone
marrow MSC to differentiate in vitro into cardio-
myocytes under certain conditions. Other authors sug-
gest the possibility of use of MSC for in vivo treatment
of injured heart and myocardial regeneration [38, 41].
Similar possibilities of mesenchymal cells were shown
in case of skeletal muscle. It was documented that after
culturing in vitro for several passages, the bone marrow
mesenchymal cell may differentiate into myocytes at the
single-cell level [29]. This observation was confirmed
in vivo by demonstration that human mesenchymal cells
engraft and differentiate into muscle cells in mouse
model of muscular dystrophy [8]. Vice versa, when the
cultured mononuclear cells isolated from old skeletal
muscle were injected into lethally irradiated mice, the
recipients’ hematopoietic system was completely re-
covered [14, 16, 23]. The same result was obtained when
the freshly isolated muscle mononuclear cell were used
as a graft [3]. According to the idea that the satellite cells
recognized as muscle stem cells are responsible for this
phenomenon [3, 17], it may be concluded that these cells
possess similar biological characteristics to hemato-
poietic cells. If any, this phenomenon should be revers-
ible and the hematopoietic cells could differentiate into
myotubes.
Differentiation of fetal liver-derived cells into
myocytes 
To investigate this possibility we selected the fetal liver
as a source of cells which were attempted to redirect into
myocytes by co-culture with muscle satellite cells. The
ability of fuse with the myotube-organizing satellite
cells would evidence myogenic capacity of the tested
cells. The liver cells were isolated from 14-day rat
(WAG) fetuses and mechanically suspended in DMEM
medium. Then the cells were cultured at concentration
1.5 × 106 per ml in 25 cm Falcon flasks in DMEM
supplemented with 10% fetal calf serum (FCS). After
7-day incubation of primary culture, the nonadherent
cells were removed. The adherent cells were trypsinized
and passaged every 10 days of culture up to 20th passage
(Fig. 1). Freshly suspended liver cells and these from
every passage were examined for hematopoietic activity
by culturing in methylcelulose supplemented with FCS
and rat IL-3, human IL-6 and Epo. The hematopoietic
colonies were counted after 12 days of incubation. Prior
to co-culture with satellite cells the fetal liver cells were
marked with fluorescent membrane dye (PKH-67). Sat-
ellite cells were obtained by pronase digestion of WAG
rats’ soleus muscle. After isolation, the satellite cells
were suspended and cultured in DMEM supplemented
with 10% FCS and 10% HS (horse serum). Following
10 days of culture the occurrence of myotubes was ob-
served (Fig. 2). Cell fusion was induced by addition of
fluorescent marked cells to 4-day satellite cell cultures.
The data was evaluated on day 7 (the beginning of fusion
process) and 9 (formed myotubes) of culture (Fig. 3). 
Culture in methylcelulose resulted in a high number
of GM and Mix colonies in case of freshly isolated liver
cells and the number of colonies decreased with the
number of passages. In case of cells from the 2nd pas-
sage, no colonies were detected in the culture. Since the
2nd passage up to the 20th passage, the hematopoietic
colonies were not detectable. In contrast, freshly isolated
cells were not able to fuse with rat satellite cells and form
the myotubes. This ability appeared in plastic-adherent
cells just from the first passage and increased to the 3rd
passage. The cells from every next passage up to the
20th, when co-cultured with satellite cells participated
in myotube formation at the same high level (Tab. 1). 
Conclusions
This result suggests that in the 14-day rat liver there exist
at least two subpopulations of cells: the non-adherent
Table 1. Changes of frequencies of fetal rat liver-derived hematopoietic progenitor cells and cell fusion with muscle satellite cells in relation
to cell culture duration. 
Primary fetal
liver cell
suspension
Primary
adherent cells
Primary
non-adherent
cells
1st passage 2nd passage 3rd passage
GM-CFC colonies/103 cells 22±4 9±3 5±3 1±1 0 0
Mix colonies/103 cells 16±2 2±1 7±2 1±1 0 0
Frequency of fusion - -/+ - + + +++
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hematopoietic cell population, and the population of
plastic-adherent cells capable of differentiating into
myotubes. Since the attempts to redifferentiate hemato-
poietic subpopulation into myogenesis, or myogenic
subpopulation into hematopoiesis failed, it may be con-
cluded that at least under our experimental conditions
the fetal liver cells do not reveal the "plasticity" features.
According to our results and those of other authors,
the fetal liver seems to be a good experimental tool for
the stem cells investigations. However, at present, there
is no evidence that the early, multipotent stem cells exist
in this tissue. Currently accessible data suggests that
mid-gestation fetal liver contains mono- or maybe uni-
potent stem cells, but not toti- or multipotent ones.
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